Cargando…
Olanzapine has poorer efficacy than risperidone for the treatment of the negative symptoms of schizophrenia
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5547874/ https://www.ncbi.nlm.nih.gov/pubmed/28827880 http://dx.doi.org/10.4103/psychiatry.IndianJPsychiatry_95_17 |
| _version_ | 1783255752306065408 |
|---|---|
| author | Vadlamani, Laxmi Naresh Banwari, Girish Dinakaran, Damodharan Menon, Vikas Andrade, Chittaranjan |
| author_facet | Vadlamani, Laxmi Naresh Banwari, Girish Dinakaran, Damodharan Menon, Vikas Andrade, Chittaranjan |
| author_sort | Vadlamani, Laxmi Naresh |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5547874 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Medknow Publications & Media Pvt Ltd |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-55478742017-08-21 Olanzapine has poorer efficacy than risperidone for the treatment of the negative symptoms of schizophrenia Vadlamani, Laxmi Naresh Banwari, Girish Dinakaran, Damodharan Menon, Vikas Andrade, Chittaranjan Indian J Psychiatry Letters to Editor Medknow Publications & Media Pvt Ltd 2017 /pmc/articles/PMC5547874/ /pubmed/28827880 http://dx.doi.org/10.4103/psychiatry.IndianJPsychiatry_95_17 Text en Copyright: © 2017 Indian Journal of Psychiatry http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
| spellingShingle | Letters to Editor Vadlamani, Laxmi Naresh Banwari, Girish Dinakaran, Damodharan Menon, Vikas Andrade, Chittaranjan Olanzapine has poorer efficacy than risperidone for the treatment of the negative symptoms of schizophrenia |
| title | Olanzapine has poorer efficacy than risperidone for the treatment of the negative symptoms of schizophrenia |
| title_full | Olanzapine has poorer efficacy than risperidone for the treatment of the negative symptoms of schizophrenia |
| title_fullStr | Olanzapine has poorer efficacy than risperidone for the treatment of the negative symptoms of schizophrenia |
| title_full_unstemmed | Olanzapine has poorer efficacy than risperidone for the treatment of the negative symptoms of schizophrenia |
| title_short | Olanzapine has poorer efficacy than risperidone for the treatment of the negative symptoms of schizophrenia |
| title_sort | olanzapine has poorer efficacy than risperidone for the treatment of the negative symptoms of schizophrenia |
| topic | Letters to Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5547874/ https://www.ncbi.nlm.nih.gov/pubmed/28827880 http://dx.doi.org/10.4103/psychiatry.IndianJPsychiatry_95_17 |
| work_keys_str_mv | AT vadlamanilaxminaresh olanzapinehaspoorerefficacythanrisperidoneforthetreatmentofthenegativesymptomsofschizophrenia AT banwarigirish olanzapinehaspoorerefficacythanrisperidoneforthetreatmentofthenegativesymptomsofschizophrenia AT dinakarandamodharan olanzapinehaspoorerefficacythanrisperidoneforthetreatmentofthenegativesymptomsofschizophrenia AT menonvikas olanzapinehaspoorerefficacythanrisperidoneforthetreatmentofthenegativesymptomsofschizophrenia AT andradechittaranjan olanzapinehaspoorerefficacythanrisperidoneforthetreatmentofthenegativesymptomsofschizophrenia |